{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:37:42Z","timestamp":1787243862883,"version":"build-2736575974"},"reference-count":106,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1097\/ppo.0b013e31826aee97","type":"journal-article","created":{"date-parts":[[2012,9,21]],"date-time":"2012-09-21T17:40:28Z","timestamp":1348249228000},"page":"411-420","source":"Crossref","is-referenced-by-count":96,"title":["The Histological and Biological Spectrum of Diffuse Large B-Cell Lymphoma in the World Health Organization Classification"],"prefix":"10.1097","volume":"18","author":[{"given":"Madhu P.","family":"Menon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Pittaluga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine S.","family":"Jaffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210203","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1182\/blood-2011-01-293050","article-title":". The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications.","volume":"117","author":"Campo","year":"2011","journal-title":"Blood"},{"key":"R2-6-20210203","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ccr.2007.08.011","article-title":". A signaling pathway mediating downregulation of BCL6 in germinal center B cells is blocked by BCL6 gene alterations in B cell lymphoma.","volume":"12","author":"Saito","year":"2007","journal-title":"Cancer Cell"},{"key":"R4-6-20210203","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1182\/blood-2009-05-220095","article-title":". MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy.","volume":"114","author":"Savage","year":"2009","journal-title":"Blood"},{"key":"R5-6-20210203","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0002-9440(10)63284-1","article-title":". BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma.","volume":"165","author":"Iqbal","year":"2004","journal-title":"Am J Pathol"},{"key":"R6-6-20210203","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nature08638","article-title":". Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma.","volume":"463","author":"Davis","year":"2010","journal-title":"Nature"},{"key":"R7-6-20210203","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nature09671","article-title":". Oncogenically active MYD88 mutations in human lymphoma.","volume":"470","author":"Ngo","year":"2011","journal-title":"Nature"},{"key":"R8-6-20210203","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/ng.892","article-title":". Analysis of the coding genome of diffuse large B-cell lymphoma.","volume":"43","author":"Pasqualucci","year":"2011","journal-title":"Nat Genet"},{"key":"R9-6-20210203","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa012914","article-title":". The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.","volume":"346","author":"Rosenwald","year":"2002","journal-title":"N Engl J Med"},{"key":"R10-6-20210203","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":". Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"key":"R11-6-20210203","doi-asserted-by":"crossref","first-page":"9991","DOI":"10.1073\/pnas.1732008100","article-title":". A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma.","volume":"100","author":"Wright","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R12-6-20210203","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1056\/NEJMoa0802885","article-title":". Stromal gene signatures in large-B-cell lymphomas.","volume":"359","author":"Lenz","year":"2008","journal-title":"N Engl J Med"},{"key":"R13-6-20210203","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1056\/NEJMoa032520","article-title":". Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes.","volume":"350","author":"Lossos","year":"2004","journal-title":"N Engl J Med"},{"key":"R14-6-20210203","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nm0102-68","article-title":". Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning.","volume":"8","author":"Shipp","year":"2002","journal-title":"Nat Med"},{"key":"R15-6-20210203","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1182\/blood-2003-07-2365","article-title":". Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project.","volume":"103","author":"Rimsza","year":"2004","journal-title":"Blood"},{"key":"R16-6-20210203","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1182\/blood-2005-04-1510","article-title":". Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions.","volume":"107","author":"Rimsza","year":"2006","journal-title":"Blood"},{"key":"R17-6-20210203","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.ccr.2011.11.006","article-title":". Combined genetic inactivation of beta2-microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma.","volume":"20","author":"Challa-Malladi","year":"2011","journal-title":"Cancer Cell"},{"key":"R18-6-20210203","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1126\/science.1153629","article-title":". Oncogenic CARD11 mutations in human diffuse large B cell lymphoma.","volume":"319","author":"Lenz","year":"2008","journal-title":"Science"},{"key":"R19-6-20210203","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1182\/blood-2010-03-272567","article-title":". MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF-kappaB-dependent lymphoma.","volume":"116","author":"Milhollen","year":"2010","journal-title":"Blood"},{"key":"R20-6-20210203","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature04687","article-title":". A loss-of-function RNA interference screen for molecular targets in cancer.","volume":"441","author":"Ngo","year":"2006","journal-title":"Nature"},{"key":"R21-6-20210203","doi-asserted-by":"crossref","first-page":"6069","DOI":"10.1182\/blood-2009-01-199679","article-title":". Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma.","volume":"113","author":"Dunleavy","year":"2009","journal-title":"Blood"},{"key":"R22-6-20210203","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/MOH.0b013e32834706ee","article-title":"Molecular signatures in the diagnosis and management of diffuse large B-cell lymphoma.","volume":"18","author":"Sweetenham","year":"2011","journal-title":"Curr Opin Hematol"},{"key":"R23-6-20210203","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":". Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"key":"R24-6-20210203","doi-asserted-by":"crossref","first-page":"7070","DOI":"10.1182\/blood-2011-04-345256","article-title":". Prognostic significance of immunohistochemical biomarkers in diffuse large B-cell lymphoma: a study from the Lunenburg Lymphoma Biomarker Consortium.","volume":"117","author":"Salles","year":"2011","journal-title":"Blood"},{"key":"R25-6-20210203","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1200\/JCO.2010.30.0368","article-title":". Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab.","volume":"29","author":"Meyer","year":"2011","journal-title":"J Clin Oncol"},{"key":"R26-6-20210203","doi-asserted-by":"crossref","first-page":"5494","DOI":"10.1158\/1078-0432.CCR-09-0113","article-title":". A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy.","volume":"15","author":"Choi","year":"2009","journal-title":"Clin Cancer Res"},{"key":"R27-6-20210203","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/modpathol.2009.73","article-title":". Prognostic impact of activated B-cell focused classification in diffuse large B-cell lymphoma patients treated with R-CHOP.","volume":"22","author":"Nyman","year":"2009","journal-title":"Mod Pathol"},{"key":"R28-6-20210203","doi-asserted-by":"crossref","first-page":"4836","DOI":"10.1182\/blood-2010-12-322362","article-title":". Gene-expression profiling and not immunophenotypic algorithms predicts prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy.","volume":"117","author":"Gutierrez-Garcia","year":"2011","journal-title":"Blood"},{"key":"R29-6-20210203","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1080\/10428190500051844","article-title":". Validation of tissue microarray immunohistochemistry staining and interpretation in diffuse large B-cell lymphoma.","volume":"46","author":"Zu","year":"2005","journal-title":"Leuk Lymphoma"},{"key":"R30-6-20210203","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/jcp.2008.057257","article-title":". Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications (a study from the Lunenburg Lymphoma Biomarker Consortium).","volume":"62","author":"de Jong","year":"2009","journal-title":"J Clin Pathol"},{"key":"R32-6-20210203","first-page":"2291","article-title":". Subclassification of diffuse large B-cell lymphomas according to the Kiel classification: distinction of centroblastic and immunoblastic lymphomas is a significant prognostic risk factor.","volume":"89","author":"Engelhard","year":"1997","journal-title":"Blood"},{"key":"R34-6-20210203","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1182\/blood-2007-10-119099","article-title":". Pathway analysis of primary central nervous system lymphoma.","volume":"111","author":"Tun","year":"2008","journal-title":"Blood"},{"key":"R35-6-20210203","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1182\/blood-2010-07-297861","article-title":". Genomic profiling combined with gene expression profiling in primary central nervous system lymphoma.","volume":"117","author":"Sung","year":"2011","journal-title":"Blood"},{"key":"R37-6-20210203","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1038\/modpathol.3800691","article-title":". Primary testicular diffuse large B-cell lymphoma belongs to the nongerminal center B-cell-like subgroup: a study of 18 cases.","volume":"19","author":"Al-Abbadi","year":"2006","journal-title":"Mod Pathol"},{"key":"R38-6-20210203","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/path.2399","article-title":". Genomic alterations and gene expression in primary diffuse large B-cell lymphomas of immune-privileged sites: the importance of apoptosis and immunomodulatory pathways.","volume":"216","author":"Booman","year":"2008","journal-title":"J Pathol"},{"key":"R40-6-20210203","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1182\/blood-2011-03-321349","article-title":"How I treat primary CNS lymphoma.","volume":"118","author":"Ferreri","year":"2011","journal-title":"Blood"},{"key":"R41-6-20210203","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":". WHO-EORTC classification for cutaneous lymphomas.","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"R42-6-20210203","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1182\/blood-2004-04-1594","article-title":". Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling.","volume":"105","author":"Hoefnagel","year":"2005","journal-title":"Blood"},{"key":"R43-6-20210203","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1182\/blood-2003-08-2726","article-title":". Bcl-2 protein expression is the strongest independent prognostic factor of survival in primary cutaneous large B-cell lymphomas.","volume":"103","author":"Grange","year":"2004","journal-title":"Blood"},{"key":"R44-6-20210203","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1200\/JCO.2006.08.2313","article-title":". Definition, diagnosis, and management of intravascular large B-cell lymphoma: proposals and perspectives from an international consensus meeting.","volume":"25","author":"Ponzoni","year":"2007","journal-title":"J Clin Oncol"},{"key":"R45-6-20210203","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.0303-6987.2005.00495.x","article-title":". WHOEORTC classification of cutaneous lymphomas 2005: histological and molecular aspects.","volume":"32","author":"Burg","year":"2005","journal-title":"J Cutan Pathol"},{"key":"R46-6-20210203","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1182\/blood-2006-01-021253","article-title":". Intravascular large B-cell lymphoma (IVLBCL): a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5.","volume":"109","author":"Murase","year":"2007","journal-title":"Blood"},{"key":"R47-6-20210203","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1046\/j.1365-2559.2002.01291.x","article-title":". Histiocyte-rich, T-cell-rich B-cell lymphoma: a distinct diffuse large B-cell lymphoma subtype showing characteristic morphologic and immunophenotypic features.","volume":"40","author":"Achten","year":"2002","journal-title":"Histopathology"},{"key":"R48-6-20210203","first-page":"1269","article-title":". T-cellhistiocyte-rich large B-cell lymphoma: a distinct clinicopathologic entity.","volume":"20","author":"Achten","year":"2002","journal-title":"J Clin Oncol"},{"key":"R49-6-20210203","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1634\/theoncologist.11-4-384","article-title":"T-cellhistiocyte-rich B-cell lymphoma: biology, diagnosis, and management.","volume":"11","author":"Abramson","year":"2006","journal-title":"Oncologist"},{"key":"R50-6-20210203","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3324\/haematol.2009.009647","article-title":". T-cellhistiocyte-rich large B-cell lymphoma shows transcriptional features suggestive of a tolerogenic host immune response.","volume":"95","author":"Van Loo","year":"2010","journal-title":"Haematologica"},{"key":"R51-6-20210203","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3324\/haematol.2009.016931","article-title":"T-cellhistiocyte-rich large B-cell lymphoma.","volume":"95","author":"Pittaluga","year":"2010","journal-title":"Haematologica"},{"key":"R52-6-20210203","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1097\/00000478-200211000-00008","article-title":". T-cellhistiocyte-rich large B-cell lymphoma: a heterogeneous entity with derivation from germinal center B cells.","volume":"26","author":"Lim","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"R53-6-20210203","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1080\/10428190500083326","article-title":". Proliferation rate and outcome in children with T-cell rich B-cell lymphoma: a clinicopathologic study from the NHL-BFM-study group.","volume":"46","author":"Tiemann","year":"2005","journal-title":"Leuk Lymphoma"},{"key":"R54-6-20210203","doi-asserted-by":"crossref","first-page":"5124","DOI":"10.1158\/1078-0432.CCR-06-2823","article-title":". Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patients.","volume":"13","author":"Oyama","year":"2007","journal-title":"Clin Cancer Res"},{"key":"R55-6-20210203","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1182\/blood-2008-06-164806","article-title":". Age-related Epstein-Barr virus (EBV)-associated B-cell lymphoproliferative disorders: comparison with EBV-positive classic Hodgkin lymphoma in elderly patients.","volume":"113","author":"Asano","year":"2009","journal-title":"Blood"},{"key":"R56-6-20210203","doi-asserted-by":"crossref","first-page":"4726","DOI":"10.1182\/blood-2010-12-323238","article-title":". Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma.","volume":"117","author":"Dojcinov","year":"2011","journal-title":"Blood"},{"key":"R57-6-20210203","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.clml.2011.07.003","article-title":". EBV-positive diffuse large B-cell lymphoma in young immunocompetent individuals.","volume":"11","author":"Beltran","year":"2011","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"R58-6-20210203","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/PAS.0b013e3181cf8622","article-title":". EBV positive mucocutaneous ulcera study of 26 cases associated with various sources of immunosuppression.","volume":"34","author":"Dojcinov","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R59-6-20210203","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/ajcp\/93.5.698","article-title":". Acute infectious mononucleosis. CD30 (Ki-1) antigen expression and histologic correlations.","volume":"93","author":"Abbondanzo","year":"1990","journal-title":"Am J Clin Pathol"},{"key":"R60-6-20210203","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1097\/00000478-199610000-00015","article-title":". Hodgkins disease and lymphoproliferations resembling Hodgkins disease in patients receiving long-term low-dose methotrexate therapy.","volume":"20","author":"Kamel","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"R61-6-20210203","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/01.pap.0000194627.50878.02","article-title":"Pyothorax-associated lymphoma: a lymphoma developing in chronic inflammation.","volume":"12","author":"Aozasa","year":"2005","journal-title":"Adv Anat Pathol"},{"key":"R62-6-20210203","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/modpathol.2009.168","article-title":". Diffuse large B-cell lymphoma associated with chronic inflammation as an incidental finding and new clinical scenarios.","volume":"23","author":"Loong","year":"2010","journal-title":"Mod Pathol"},{"key":"R63-6-20210203","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/annonc\/mdl349","article-title":". Clinicopathological features of pyothorax-associated lymphoma; a retrospective survey involving 98 patients.","volume":"18","author":"Narimatsu","year":"2007","journal-title":"Ann Oncol"},{"key":"R64-6-20210203","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.1200\/JCO.2002.09.021","article-title":". Pyothorax-associated lymphoma: a review of 106 cases.","volume":"20","author":"Nakatsuka","year":"2002","journal-title":"J Clin Oncol"},{"key":"R65-6-20210203","first-page":"229","article-title":"Joos S, et al..","volume":"3","author":"Barth","year":"2002","journal-title":"Mediastinal (thymic) large B-cell lymphoma: where do we stand Lancet Oncol"},{"key":"R66-6-20210203","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1182\/blood-2010-05-282780","article-title":". Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma.","volume":"116","author":"Green","year":"2010","journal-title":"Blood"},{"key":"R67-6-20210203","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1182\/blood-2004-12-4901","article-title":". NFkappaB activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes.","volume":"106","author":"Feuerhake","year":"2005","journal-title":"Blood"},{"key":"R68-6-20210203","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.ccr.2010.11.013","article-title":". Cooperative epigenetic modulation by cancer amplicon genes.","volume":"18","author":"Rui","year":"2010","journal-title":"Cancer Cell"},{"key":"R69-6-20210203","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3324\/haematol.2010.030809","article-title":". Clinical, pathological and genetic features of primary mediastinal large B-cell lymphomas and mediastinal gray zone lymphomas in children.","volume":"96","author":"Oschlies","year":"2011","journal-title":"Haematologica"},{"key":"R70-6-20210203","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1084\/jem.20031074","article-title":". Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma.","volume":"198","author":"Rosenwald","year":"2003","journal-title":"J Exp Med"},{"key":"R71-6-20210203","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1182\/blood-2003-06-1841","article-title":". The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma.","volume":"102","author":"Savage","year":"2003","journal-title":"Blood"},{"key":"R72-6-20210203","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/01.pas.0000213334.40358.0e","article-title":". Expression of TRAF1 and nuclear c-Rel distinguishes primary mediastinal large cell lymphoma from other types of diffuse large B-cell lymphoma.","volume":"31","author":"Rodig","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R73-6-20210203","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1097\/01.pas.0000180856.74572.73","article-title":". Mediastinal gray zone lymphoma: the missing link between classic Hodgkins lymphoma and mediastinal large B-cell lymphoma.","volume":"29","author":"Traverse-Glehen","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R76-6-20210203","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s11912-011-0189-5","article-title":"Primary mediastinal DLBCL: evolving biologic understanding and therapeutic strategies.","volume":"13","author":"Zinzani","year":"2011","journal-title":"Curr Oncol Rep"},{"key":"R77-6-20210203","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1182\/blood.V89.5.1483","article-title":". A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2; 5 translocation.","volume":"89","author":"Delsol","year":"1997","journal-title":"Blood"},{"key":"R78-6-20210203","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1038\/sj.leu.2403921","article-title":". ALK-positive diffuse large B-cell lymphoma with ALK-clathrin fusion belongs to the spectrum of pediatric lymphomas.","volume":"19","author":"Gesk","year":"2005","journal-title":"Leukemia"},{"key":"R79-6-20210203","doi-asserted-by":"crossref","first-page":"4211","DOI":"10.1200\/JCO.2008.21.5020","article-title":". Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma: a rare clinicopathologic entity with poor prognosis.","volume":"27","author":"Laurent","year":"2009","journal-title":"J Clin Oncol"},{"key":"R80-6-20210203","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3324\/haematol.2010.031484","article-title":". Cytogenetically complex SEC31A-ALK fusions are recurrent in ALK-positive large B-cell lymphomas.","volume":"96","author":"Bedwell","year":"2011","journal-title":"Haematologica"},{"key":"R81-6-20210203","doi-asserted-by":"crossref","first-page":"529572","DOI":"10.1155\/2012\/529572","article-title":"Anaplastic lymphoma kinase-positive large B-cell lymphoma: an underrecognized aggressive lymphoma.","volume":"2012","author":"Morgan","year":"2012","journal-title":"Adv Hematol"},{"key":"R82-6-20210203","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1056\/NEJMp1100548","article-title":"Early accelerated approval for highly targeted cancer drugs.","volume":"364","author":"Chabner","year":"2011","journal-title":"N Engl J Med"},{"key":"R83-6-20210203","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1182\/blood.V89.4.1413","article-title":". Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection.","volume":"89","author":"Delecluse","year":"1997","journal-title":"Blood"},{"key":"R84-6-20210203","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1097\/01.pas.0000126781.87158.e3","article-title":". Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities.","volume":"28","author":"Colomo","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"R85-6-20210203","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/modpathol.3800355","article-title":". Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles.","volume":"18","author":"Vega","year":"2005","journal-title":"Mod Pathol"},{"key":"R86-6-20210203","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/modpathol.2010.72","article-title":". Plasmablastic lymphoma with MYC translocation: evidence for a common pathway in the generation of plasmablastic features.","volume":"23","author":"Taddesse-Heath","year":"2010","journal-title":"Mod Pathol"},{"key":"R87-6-20210203","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1097\/PAS.0b013e3181f3e29f","article-title":". IGMYC rearrangements are the main cytogenetic alteration in plasmablastic lymphomas.","volume":"34","author":"Valera","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R88-6-20210203","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/gcc.20563","article-title":". Secondary genomic rearrangements involving immunoglobulin or MYC loci show similar prevalences in hyperdiploid and nonhyperdiploid myeloma tumors.","volume":"47","author":"Gabrea","year":"2008","journal-title":"Genes Chromosomes Cancer"},{"key":"R89-6-20210203","first-page":"1547","article-title":"Plasmablastic lymphoma: are more intensive regimens needed Leuk Res.","volume":"35","author":"Castillo","year":"2011","journal-title":""},{"key":"R91-6-20210203","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1056\/NEJM199505043321802","article-title":". Kaposis sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas.","volume":"332","author":"Cesarman","year":"1995","journal-title":"N Engl J Med"},{"key":"R92-6-20210203","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/(SICI)1096-9896(199910)189:2<288::AID-PATH419>3.0.CO;2-F","article-title":". Expression of potentially oncogenic HHV-8 genes in an EBV-negative primary effusion lymphoma occurring in an HIV-seronegative patient.","volume":"189","author":"Cobo","year":"1999","journal-title":"J Pathol"},{"key":"R93-6-20210203","first-page":"1637","article-title":". Expression of human herpesvirus-8 oncogene and cytokine homologues in an HIV-seronegative patient with multicentric Castlemans disease and primary effusion lymphoma.","volume":"78","author":"Teruya-Feldstein","year":"1998","journal-title":"Lab Invest"},{"key":"R94-6-20210203","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1097\/01.pas.0000138177.10829.5c","article-title":". KSHV-positive solid lymphomas represent an extra-cavitary variant of primary effusion lymphoma.","volume":"28","author":"Chadburn","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"R95-6-20210203","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1097\/00000478-200206000-00005","article-title":". Pyothorax-associated lymphoma: a peculiar clinicopathologic entity derived from B cells at late stage of differentiation and with occasional aberrant dual B- and T-cell phenotype.","volume":"26","author":"Petitjean","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"R96-6-20210203","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1097\/00000478-199908000-00023","article-title":". A biophenotypic human herpesvirus 8-associated primary bowel lymphoma.","volume":"23","author":"Beaty","year":"1999","journal-title":"Am J Surg Pathol"},{"key":"R97-6-20210203","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.4161\/cbt.10.10.13291","article-title":". Kaposi sarcoma-associated herpesvirus-encoded viral FLICE inhibitory protein (vFLIP) K13 cooperates with Myc to promote lymphoma in mice.","volume":"10","author":"Ahmad","year":"2010","journal-title":"Cancer Biol Ther"},{"key":"R98-6-20210203","doi-asserted-by":"crossref","first-page":"4979","DOI":"10.1038\/sj.onc.1210299","article-title":"Deregulation of c-Myc in primary effusion lymphoma by Kaposis sarcoma herpesvirus latency-associated nuclear antigen.","volume":"26","author":"Bubman","year":"2007","journal-title":"Oncogene"},{"key":"R99-6-20210203","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1182\/blood.V95.4.1406.004k26_1406_1412","article-title":". HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma.","volume":"95","author":"Dupin","year":"2000","journal-title":"Blood"},{"key":"R100-6-20210203","first-page":"486","article-title":". Castleman disease in the 21st century: an update on diagnosis, assessment, and therapy.","volume":"8","author":"van Rhee","year":"2010","journal-title":"Clin Adv Hematol Oncol"},{"key":"R101-6-20210203","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1097\/PAS.0b013e31804d43d8","article-title":". HHV-8, EBV multicentric plasmablastic microlymphoma in an HIV man: the spectrum of HHV-8 lymphoproliferative disorders expands.","volume":"31","author":"Seliem","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R102-6-20210203","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1182\/blood-2010-09-297879","article-title":". Double-hit B-cell lymphomas.","volume":"117","author":"Aukema","year":"2011","journal-title":"Blood"},{"key":"R103-6-20210203","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1182\/asheducation-2011.1.506","article-title":"Aggressive B-cell lymphomas: a review of new and old entities in the WHO classification.","volume":"2011","author":"Jaffe","year":"2011","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"R104-6-20210203","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMoa055759","article-title":". Molecular diagnosis of Burkitts lymphoma.","volume":"354","author":"Dave","year":"2006","journal-title":"N Engl J Med"},{"key":"R105-6-20210203","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa055351","article-title":". A biologic definition of Burkitts lymphoma from transcriptional and genomic profiling.","volume":"354","author":"Hummel","year":"2006","journal-title":"N Engl J Med"},{"key":"R106-6-20210203","doi-asserted-by":"crossref","first-page":"935","DOI":"10.3324\/haematol.2008.005355","article-title":". Clinicopathological features of lymphomaleukemia patients carrying both BCL2 and MYC translocations.","volume":"94","author":"Tomita","year":"2009","journal-title":"Haematologica"},{"key":"R107-6-20210203","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/PAS.0b013e3181cd3aeb","article-title":". B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.","volume":"34","author":"Snuderl","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R108-6-20210203","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1182\/blood-2009-03-212191","article-title":". Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival.","volume":"114","author":"Johnson","year":"2009","journal-title":"Blood"},{"key":"R110-6-20210203","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1097\/01.pas.0000168176.71405.e5","article-title":". Clinical, immunophenotypic, and genetic analysis of adult lymphomas with morphologic features of Burkitt lymphoma.","volume":"29","author":"Haralambieva","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R112-6-20210203","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1200\/JCO.2009.26.3947","article-title":". Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab.","volume":"28","author":"Barrans","year":"2010","journal-title":"J Clin Oncol"},{"key":"R114-6-20210203","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1038\/modpathol.2011.116","article-title":". Gray zone lymphoma: chromosomal aberrations with immunophenotypic and clinical correlations.","volume":"24","author":"Eberle","year":"2011","journal-title":"Mod Pathol"},{"key":"R115-6-20210203","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1200\/JCO.1996.14.3.955","article-title":". Anaplastic large-cell lymphoma: clinical and prognostic evaluation of 90 adult patients.","volume":"14","author":"Zinzani","year":"1996","journal-title":"J Clin Oncol"},{"key":"R116-6-20210203","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3324\/haematol.2010.033167","article-title":". Methylation profiling of mediastinal gray zone lymphoma reveals a distinctive signature with elements shared by classical Hodgkins lymphoma and primary mediastinal large B-cell lymphoma.","volume":"96","author":"Eberle","year":"2011","journal-title":"Haematologica"},{"key":"R117-6-20210203","doi-asserted-by":"crossref","first-page":"758","DOI":"10.3324\/haematol.2011.056531","article-title":". A Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype.","volume":"97","author":"Wilson","year":"2012","journal-title":"Haematologica"}],"container-title":["The Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PPO.0b013e31826aee97","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T08:33:25Z","timestamp":1643445205000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00130404-201209000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":106,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/ppo.0b013e31826aee97","relation":{},"ISSN":["1528-9117"],"issn-type":[{"value":"1528-9117","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}